Page 10 - ஷாய் பிரன் News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Molecular Partners Reports Corporate Highlights from Q4 2020 and Key Financials for FY2020
tennesseedaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tennesseedaily.com Daily Mail and Mail on Sunday newspapers.
Molecular Partners and Novartis COVID-19 Antiviral Candidate, Ensovibep, Maintains Binding and Neutralization of New Viral Variants in vitro
newjerseytelegraph.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from newjerseytelegraph.com Daily Mail and Mail on Sunday newspapers.
Molecular Partners to Present at Upcoming Healthcare Investor Conferences
pittsburghstar.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from pittsburghstar.com Daily Mail and Mail on Sunday newspapers.
Molecular Partners AG: Molecular Partners to Present at Upcoming Healthcare Investor Conferences
ZURICH-SCHLIEREN, SWITZERLAND / ACCESSWIRE / January 6, 2021 / Molecular Partners AG (SIX:MOLN), a clinical-stage biotech company developing a new class of custom-built protein drugs known as DARPin® therapeutics, today announced that its Chief Executive Officer, Patrick Amstutz, Ph.D., will present at or attend several upcoming virtual healthcare investor events in January, 2021.
Conference Presentation Details:
Date/Time: Monday, January 11, 2021 at 6:00 a.m. ET (12:00 p.m. CET)
Event: Baader Helvea Swiss Equities Conference
Date/Time: Wednesday, January 13, 2021 at 1:00 p.m. CET (7:00 a.m. ET)
Event: JP Morgan 39
Date/Time: Thursday, January 14, 2021 at 7:30 a.m. ET (1:30 p.m. CET)